Table 1.
Reference | Study Design | Country | Sample Size | AKI Definition | Population | RRT | Intervention | Comparator | Assessment of Fluid Status | Duration of Intervention | Difference in FB | Outcome Measures |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Effat 2021 | SC RCT, Unblinded | Egypt | 40 (20/20) | Unclear | AKI, ICU | Non-RRT patients | Echo-directed SVV fluid administration | CVP-directed fluid | Incomplete | 48 h | Fluid input (2200 mL vs 3700 mL; p < 0.01). No UO or FB data. | ICU LOS (6.4 days vs 12.1 days; p = 0.183). Mortality (10% vs 40%; p = 0.028). |
O'Brien 2022 | Post hoc analysis of RENAL MC RCT | Australia & New Zealand | 771 | On CRRT. | ICU; CRRT | RRT as inclusion criteria | 1) 20% albumin 2) 20% and 4% albumin | 4% albumin | Cumulative fluid balance | Until CRRT cessation or ICU discharge | Daily FB (20% HAS 288 mL, 4% HAS 245 mL, combined HAS 88 mL (p < 0.001). Cumulative FB (1.9 L vs −2.4 vs 1.3; p < 0.01). | Mortality at day 90 (4% HAS 48% vs 20% HAS 52% vs Combined HAS 51%; p = 0.65); RRT dependence at day 90 (6.7% vs 5.3% vs 3.8%; p = 0.59). |
Abbreviations: AKI = acute kidney injury; SC = single-centre; MC = multicentre; RCT = randomised controlled trial; CRRT = continuous renal replacement therapy; RRT = renal replacement therapy; ICU = intensive care unit; FB = fluid balance; UO = urine output; RENAL = Randomized Evaluation of Normal versus Augmented Level; HAS = human albumin solution; LOS = length of stay; CVP = central venous pressure.